BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Portincasa P, Krawczyk M, Machill A, Lammert F, Di Ciaula A. Hepatic consequences of COVID-19 infection. Lapping or biting? Eur J Intern Med. 2020;77:18-24. [PMID: 32507608 DOI: 10.1016/j.ejim.2020.05.035] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 17.5] [Reference Citation Analysis]
Number Citing Articles
1 Idalsoaga F, Ayares G, Arab JP, Díaz LA. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence. J Clin Transl Hepatol 2021;9:760-8. [PMID: 34722191 DOI: 10.14218/JCTH.2020.00140] [Reference Citation Analysis]
2 Wiśniewska H, Skonieczna-Żydecka K, Parczewski M, Niścigorska-Olsen J, Karpińska E, Hornung M, Jurczyk K, Witak-Jędra M, Laurans Ł, Maciejewska K, Socha Ł, Leonciuk A, Bander D, Karasińska-Cieślak M, Aksak-Wąs B, Wawrzynowicz-Syczewska M. Hepatotropic Properties of SARS-CoV-2-Preliminary Results of Cross-Sectional Observational Study from the First Wave COVID-19 Pandemic. J Clin Med 2021;10:672. [PMID: 33572429 DOI: 10.3390/jcm10040672] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Xu Y, Yang X, Bian H, Xia M. Metabolic dysfunction associated fatty liver disease and coronavirus disease 2019: clinical relationship and current management. Lipids Health Dis 2021;20:126. [PMID: 34602072 DOI: 10.1186/s12944-021-01564-z] [Reference Citation Analysis]
4 Clark R, Waters B, Stanfill AG. Elevated liver function tests in COVID-19: Causes, clinical evidence, and potential treatments.Nurse Pract. 2021;46:21-26. [PMID: 33332825 DOI: 10.1097/01.NPR.0000722316.63824.f9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lee A, Wein AN, Doyle MBM, Chapman WC. Liver transplantation for post-COVID-19 sclerosing cholangitis. BMJ Case Rep 2021;14:e244168. [PMID: 34446515 DOI: 10.1136/bcr-2021-244168] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 McGrowder DA, Miller F, Anderson Cross M, Anderson-Jackson L, Bryan S, Dilworth L. Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis. Diseases 2021;9:50. [PMID: 34287285 DOI: 10.3390/diseases9030050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Lucas K, Fröhlich-Nowoisky J, Oppitz N, Ackermann M. Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases. Front Plant Sci 2021;12:589783. [PMID: 33719281 DOI: 10.3389/fpls.2021.589783] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zhao W, Zhang X, Zhu F, Jiang X. Dynamic Changes of Liver Function Indexes in Patients with Different Clinical Types of COVID-19. IJGM 2022;Volume 15:877-84. [DOI: 10.2147/ijgm.s347291] [Reference Citation Analysis]
9 Sheng L, Wang X, Tang N, Meng F, Huang L, Li D. Clinical characteristics of moderate and severe cases with COVID-19 in Wuhan, China: a retrospective study. Clin Exp Med 2021;21:35-9. [PMID: 32949308 DOI: 10.1007/s10238-020-00662-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Bonaventura A, Vecchié A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M, Abbate A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 2021;21:319-29. [PMID: 33824483 DOI: 10.1038/s41577-021-00536-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 40] [Article Influence: 33.0] [Reference Citation Analysis]
11 Tafreshi S, Whiteside I, Levine I, D'Agostino C. A case of secondary sclerosing cholangitis due to COVID-19. Clin Imaging 2021;80:239-42. [PMID: 34364072 DOI: 10.1016/j.clinimag.2021.07.017] [Reference Citation Analysis]
12 Weber S, Hellmuth JC, Scherer C, Muenchhoff M, Mayerle J, Gerbes AL. Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study. Gut 2021:gutjnl-2020-323800. [PMID: 33514597 DOI: 10.1136/gutjnl-2020-323800] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 12.0] [Reference Citation Analysis]
13 Madian A, Eliwa A, Abdalla H, Aly HAA. Hepatocellular injury and the mortality risk among patients with COVID-19: A retrospective cohort study. World J Hepatol 2021; 13(8): 939-948 [PMID: 34552700 DOI: 10.4254/wjh.v13.i8.939] [Reference Citation Analysis]
14 Vasques-Monteiro IML, Souza-Mello V. Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight. World J Gastroenterol 2021; 27(16): 1738-1750 [PMID: 33967554 DOI: 10.3748/wjg.v27.i16.1738] [Cited by in CrossRef: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Kaviani M, Keshtkar S, Soleimanian S, Sabet Sarvestani F, Azarpira N, Pakbaz S. Susceptibility to Metabolic Diseases in COVID-19: To be or Not to be an Issue. Front Mol Biosci 2022;9:803314. [DOI: 10.3389/fmolb.2022.803314] [Reference Citation Analysis]
16 Chinnici CM, Russelli G, Bulati M, Miceli V, Gallo A, Busà R, Tinnirello R, Conaldi PG, Iannolo G. Mesenchymal stromal cell secretome in liver failure: Perspectives on COVID-19 infection treatment. World J Gastroenterol 2021; 27(17): 1905-1919 [PMID: 34007129 DOI: 10.3748/wjg.v27.i17.1905] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Lin S, Kantor R, Clark E. Coronavirus Disease 2019. Clin Geriatr Med 2021;37:509-22. [PMID: 34600718 DOI: 10.1016/j.cger.2021.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gupta S, Mitra A. Challenge of post-COVID era: management of cardiovascular complications in asymptomatic carriers of SARS-CoV-2. Heart Fail Rev 2021. [PMID: 33426593 DOI: 10.1007/s10741-021-10076-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Du M, Yang DS, Liu M, Liu J. COVID-19 and Liver dysfunction: Epidemiology, Association and Potential Mechanisms. Clin Res Hepatol Gastroenterol 2021;:101793. [PMID: 34428501 DOI: 10.1016/j.clinre.2021.101793] [Reference Citation Analysis]
20 Di Ciaula A, Palmieri VO, Migliore G, Portincasa P; IMC-19 Group. COVID-19, internists and resilience: the north-south Italy outbreak. Eur J Clin Invest 2020;50:e13299. [PMID: 32480424 DOI: 10.1111/eci.13299] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ronderos D, Omar AMS, Abbas H, Makker J, Baiomi A, Sun H, Mantri N, Choi Y, Fortuzi K, Shin D, Patel H, Chilimuri S. Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality. World J Clin Cases 2021; 9(29): 8749-8762 [PMID: 34734053 DOI: 10.12998/wjcc.v9.i29.8749] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Stella A, Lamkanfi M, Portincasa P. Familial Mediterranean Fever and COVID-19: Friends or Foes? Front Immunol 2020;11:574593. [PMID: 33072117 DOI: 10.3389/fimmu.2020.574593] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
23 Di Ciaula A, Krawczyk M, Filipiak KJ, Geier A, Bonfrate L, Portincasa P. Noncommunicable diseases, climate change and iniquities: What COVID-19 has taught us about syndemic. Eur J Clin Invest 2021;51:e13682. [PMID: 34551123 DOI: 10.1111/eci.13682] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Tsutsumi T, Saito M, Nagai H, Yamamoto S, Ikeuchi K, Lim LA, Adachi E, Koga M, Okushin K, Akai H, Kunimatsu A, Yotsuyanagi H. Association of coagulopathy with liver dysfunction in patients with COVID-19. Hepatol Res. 2021;51:227-232. [PMID: 33047431 DOI: 10.1111/hepr.13577] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
25 Sweed D, Abdelsameea E, Khalifa EA, Abdallah H, Moaz H, Moaz I, Abdelsattar S, Abdel-Rahman N, Mosbeh A, Elmahdy HA, Sweed E. SARS-CoV-2-associated gastrointestinal and liver diseases: what is known and what is needed to explore. Egypt Liver J 2021;11:64. [PMID: 34777871 DOI: 10.1186/s43066-021-00123-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Serra F, Bonaduce I, De Ruvo N, Cautero N, Brugioni L, Gelmini R. Covid-19 and hepatic injury: A systematic review. Clin Res Hepatol Gastroenterol 2021;45:101605. [PMID: 33607550 DOI: 10.1016/j.clinre.2020.101605] [Reference Citation Analysis]
28 Krishnan A, Prichett L, Tao X, Alqahtani SA, Hamilton JP, Mezey E, Strauss AT, Kim A, Potter JJ, Chen PH, Woreta TA. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients. World J Gastroenterol 2022; 28(5): 570-587 [DOI: 10.3748/wjg.v28.i5.570] [Reference Citation Analysis]
29 Pötter-Lang S, Ba-Ssalamah A, Bastati N, Messner A, Kristic A, Ambros R, Herold A, Hodge JC, Trauner M. Modern imaging of cholangitis. Br J Radiol 2021;94:20210417. [PMID: 34233488 DOI: 10.1259/bjr.20210417] [Reference Citation Analysis]
30 Fallatah HI, Al Ghamdi WS, Al Dosari SM, Jabbad AH, Fagih M, Akbar HO. Association of COVID-19 with Hepatic Injury Prevalence and Associated Factors. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.121160] [Reference Citation Analysis]
31 Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses?‎ World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
32 Levy E, Stintzi A, Cohen A, Desjardins Y, Marette A, Spahis S. Critical appraisal of the mechanisms of gastrointestinal and hepatobiliary infection by COVID-19. Am J Physiol Gastrointest Liver Physiol 2021;321:G99-G112. [PMID: 34009033 DOI: 10.1152/ajpgi.00106.2021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Siparsky N. The Juice Versus the Squeeze. Crit Care Med 2021;49:716-8. [PMID: 33731614 DOI: 10.1097/CCM.0000000000004857] [Reference Citation Analysis]
34 Ortiz GX, Lenhart G, Becker MW, Schwambach KH, Tovo CV, Blatt CR. Drug-induced liver injury and COVID-19: A review for clinical practice. World J Hepatol 2021; 13(9): 1143-1153 [PMID: 34630881 DOI: 10.4254/wjh.v13.i9.1143] [Reference Citation Analysis]
35 Palacios S, Schiappacasse G, Valdes R, Maldonado I, Varela C. COVID-19: Abdominal and Pelvic Imaging Findings: A Primer for Radiologists. J Comput Assist Tomogr 2021;45:352-8. [PMID: 33797437 DOI: 10.1097/RCT.0000000000001152] [Reference Citation Analysis]
36 McDonald JT, Enguita FJ, Taylor D, Griffin RJ, Priebe W, Emmett MR, Sajadi MM, Harris AD, Clement J, Dybas JM, Aykin-Burns N, Guarnieri JW, Singh LN, Grabham P, Baylin SB, Yousey A, Pearson AN, Corry PM, Saravia-Butler A, Aunins TR, Sharma S, Nagpal P, Meydan C, Foox J, Mozsary C, Cerqueira B, Zaksas V, Singh U, Wurtele ES, Costes SV, Davanzo GG, Galeano D, Paccanaro A, Meinig SL, Hagan RS, Bowman NM, Wolfgang MC, Altinok S, Sapoval N, Treangen TJ, Moraes-Vieira PM, Vanderburg C, Wallace DC, Schisler JC, Mason CE, Chatterjee A, Meller R, Beheshti A; UNC COVID-19 Pathobiology Consortium. Role of miR-2392 in driving SARS-CoV-2 infection. Cell Rep 2021;37:109839. [PMID: 34624208 DOI: 10.1016/j.celrep.2021.109839] [Reference Citation Analysis]
37 Archambault AS, Zaid Y, Rakotoarivelo V, Turcotte C, Doré É, Dubuc I, Martin C, Flamand O, Amar Y, Cheikh A, Fares H, El Hassani A, Tijani Y, Côté A, Laviolette M, Boilard É, Flamand L, Flamand N. High levels of eicosanoids and docosanoids in the lungs of intubated COVID-19 patients. FASEB J 2021;35:e21666. [PMID: 34033145 DOI: 10.1096/fj.202100540R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
38 Román LE, Gomez ED, Solís JL, Gómez MM. Antibacterial Cotton Fabric Functionalized with Copper Oxide Nanoparticles. Molecules 2020;25:E5802. [PMID: 33316935 DOI: 10.3390/molecules25245802] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Mikolasevic I, Bozic D, Pavić T, Ruzic A, Hauser G, Radic M, Radic-Kristo D, Razov-Radas M, Puljiz Z, Milic S. Liver disease in the era of COVID-19: Is the worst yet to come? World J Gastroenterol 2021; 27(36): 6039-6052 [PMID: 34629818 DOI: 10.3748/wjg.v27.i36.6039] [Reference Citation Analysis]
40 Pott-Junior H, Bittencourt NQP, Chacha SFG, Luporini RL, Cominetti MR, Anibal FF. Elevations in Liver Transaminases in COVID-19: (How) Are They Related? Front Med (Lausanne) 2021;8:705247. [PMID: 34336904 DOI: 10.3389/fmed.2021.705247] [Reference Citation Analysis]